Full notification file
Member State to which the notification was sent
Date of acknowledgement from the Member State Competent Authority
Title of the Project
Study TG1024.01: "Phase I multicentre study of TG1024 (Adenovirus interleukin 2) in patients with metastatic melanoma or other advanced solid tumor cancers"
Proposed period of release:
01/05/2004 to 31/05/2005
Name of the Institute(s) or Company(ies)
Transgene S.A., ;
3. Is the same GMO release planned elsewhere in the Community?
Has the same GMO been notified elsewhere by the same notifier?
GMO is a:
Identity of the GMO:
Non replicative, recombinant adenovirus of type 5 (group C) deleted in regions E1 and E3, named ADTG13383.
Information relating to the recipient or parental organisms from wich the GMO is derived
Adenovirus human serotype 5 (Ad5)
Human adenovirus type 5
European Commission administrative information
Consent given by the Member State Competent Authority: